Related Experiment Video
Updated: Jun 23, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma
Jinyuan Zhang1, Baojun Duan1,2, Fang Li1
1Institute of Genetics and Development Biology, Translational Medcine Institute, Xi'an Jiaotong University, Xi'an 710301, China.
Abstract:
SET domain containing 7(SETD7), a member of histone methyltransferases, is abnormally expressed in multiple tumor types. However, the biological function and underlying molecular mechanism of SETD7 in clear cell renal cell carcinoma (ccRCC) remain unclear. Here, we explored the biological effects of SETD7-TAF7-CCNA2 axis on proliferation and metastasis in ccRCC. We identified both SETD7 and TAF7 were up-regulated and significantly promoted the proliferation and migration of ccRCC cells. Concurrently, there was a significant positive correlation between the expression of SETD7 and TAF7, and the two were colocalized in the nucleus. Mechanistically, SETD7 methylates TAF7 at K5 and K300 sites, resulting in the deubiquitination and stabilization of TAF7. Furthermore, re-expression of TAF7 could partially restore SETD7 knockdown inhibited ccRCC cells proliferation and migration. In addition, TAF7 transcriptionally activated to drive the expression of cyclin A2 (CCNA2). And more importantly, the methylation of TAF7 at K5 and K300 sites exhibited higher transcriptional activity of CCNA2, which promotes formation and progression of ccRCC. Our findings reveal a unique mechanism that SETD7 mediated TAF7 methylation in regulating transcriptional activation of CCNA2 in ccRCC progression and provide a basis for developing effective therapeutic strategies by targeting members of SETD7-TAF7-CCNA2 axis.
Insights
SET domain containing 7 (SETD7) promotes clear cell renal cell carcinoma (ccRCC) progression by methylating TAF7, stabilizing it, and increasing CCNA2 expression. This SETD7-TAF7-CCNA2 axis offers potential therapeutic targets for ccRCC.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- SET domain containing 7 (SETD7), a histone methyltransferase, shows abnormal expression in various cancers.
- The role and mechanism of SETD7 in clear cell renal cell carcinoma (ccRCC) are not well understood.
Purpose of the Study:
- To investigate the biological effects of the SETD7-TAF7-CCNA2 axis on ccRCC proliferation and metastasis.
- To elucidate the molecular mechanism by which SETD7 influences ccRCC progression.
Main Methods:
- Analysis of SETD7 and TAF7 expression and correlation in ccRCC tissues.
- Investigation of SETD7's methylation of TAF7 at specific sites (K5, K300) and its effect on TAF7 stability.
- Assessment of TAF7's role in regulating CCNA2 expression and its impact on ccRCC cell proliferation and migration.
Main Results:
- SETD7 and TAF7 were upregulated in ccRCC and promoted cell proliferation and migration.
- SETD7 directly methylates TAF7 at K5 and K300, leading to TAF7 deubiquitination and stabilization.
- TAF7 transcriptionally activates CCNA2, and SETD7-mediated TAF7 methylation enhances this activity, promoting ccRCC.
- Restoring TAF7 partially rescued the inhibitory effects of SETD7 knockdown on ccRCC cells.
Conclusions:
- SETD7-mediated methylation of TAF7 is a key mechanism regulating CCNA2 transcription in ccRCC.
- The SETD7-TAF7-CCNA2 axis plays a crucial role in ccRCC formation and progression.
- Targeting the SETD7-TAF7-CCNA2 axis presents a potential therapeutic strategy for ccRCC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
The Tumor Microenvironment
Replicative Cell Senescence

